Concepedia

Ahmad Aljijakli

AA

Statistics

Publications

3

Citations

1K

H-Index

3

Active since

2003

Affiliations

Inserm(Current)

Institut Gustave Roussy

Hôpital Saint-Louis

Délégation Paris 7

Assistance Publique – Hôpitaux de Paris

Ahmad Aljijakli is an author at Inserm specializing in medicine, oncology, and pharmacotherapy.

Top concepts

MedicineOncologyPathologyHematologyImmunologySclerodermaPharmacologyCancer ResearchPharmacotherapyAutoimmune Disease

Publications per year

2003–2021

3

Publications

3

Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study

Sylvie Castaigné, Cécile Pautas, Christine Terré et al. · The Lancet · 2012 · 975 citations

Hematological Malignancy, Oncology, Gemtuzumab Ozogamicin +8

A case of multicentric Castleman's disease associated with advanced systemic amyloidosis treated with chemotherapy and anti-CD20 monoclonal antibody

Dany Gholam, J Vantelon, Ahmad Aljijakli et al. · Annals of Hematology · 2003 · 39 citations

Alzheimer's Disease, Autoimmune Disease, Immunology +6

Characteristics and outcome of patients with low-/intermediate-risk acute promyelocytic leukemia treated with arsenic trioxide: an international collaborative study

Sabine Käyser, Richard F. Schlenk, Delphine Lebon et al. · Haematologica · 2021 · 21 citations · Full text

1–3 of 3